Ferndale Pharma Group, Inc.

780 W 8 Mile Rd
Ferndale, MI, 48220-2422  United States
(248) 548-0900
Company Type: Corporation Parent

D&B Business Directory

Ferndale Pharma Group wants to help your skin flourish. Through a handful of healthcare specialty companies, the holding company is responsible for producing and distributing prescription, generic, and over-the-counter (OTC) medications. Its products primarily treat skin maladies. Ferndale Pharma Group also produces topical pain relief creams, surgical adhesives, and adhesive removers. The company markets and distributes its products internationally to physicians, hospitals, and consumers. It also offers contract drug manufacturing, warehousing, and distribution services to third parties. Ferndale Pharma Group was founded in 1897 as the J.F. Hartz Company.

Try D&B Hoovers Free

Ferndale Pharma Group, Inc.

Corporation Parent
Address
780 W 8 Mile Rd
Ferndale ​, MI, 48220-2422
United States
See other locations
Phone
(248) 548-0900
Company Description

Ferndale Pharma Group wants to help your skin flourish. Through a handful of healthcare specialty companies, the holding company is responsible for producing and distributing prescription, generic, and over-the-counter (OTC) medications. Its products primarily treat skin maladies. Ferndale Pharma Group also produces topical pain relief creams, surgical adhesives, and adhesive removers. The company markets and distributes its products internationally to physicians, hospitals, and consumers. It also offers contract drug manufacturing, warehousing, and distribution services to third parties. Ferndale Pharma Group was founded in 1897 as the J.F. Hartz Company.

Key Principal
Michael Burns See more contacts
Industry
Pharmaceutical Manufacturing Manufacturing Sector Pharmaceutical preparations Surgical and medical instruments
D&B Hoovers Logo

For dynamic search and list-building capabilities, real-time trigger alerts, comprehensive company profiles, and valuable research and technology reports try D&B Hoovers for free!

Financial Statements

Revenue in USD

Annual Revenue2018
$63.92 million USD

Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.

Company Snapshot

Essential information for a successful call

  •  EMPLOYEES (This Site) 260
  •  EMPLOYEES (All Sites) 280
  •  REVENUE (MIL USD) 63.92
  • Year Started 1897
  • Incorporated 2004
  • FISCAL YEAR END NOV

Get in Touch with 3 Principals* and 6 Contacts

A D&B Hoovers Subscription is your foot in the door to Ferndale Pharma Group, Inc. contact information.
  • Michael Burns
    President and Chief Operating Officer
  • JAMES MCMILLAN
    Chief Executive Officer and Chairperson
  • MARK DIEKMAN
    Vice President and Chief Financial Officer
  • Crysta Seneski
    Associate Director of Marketing

Want more contacts like these available directly in your inbox? Install D&B Email IQ to access your next prospects!

Free Install

Related Products

Grow Business FasterLearn More
D&B Finance Analytics Credit IntelligenceIntelligent Risk ManagementLearn More
Free Microsoft Outlook plugin to drive efficiency with on-demand sales intelligenceFree Install

Get full access to D&B Hoovers

With a Hoovers subscription you can get a comprehensive view of Ferndale Pharma Group, Inc.

Ferndale Pharma Group, Inc.*

3
Principals
See who the company's key decision makers are
6
Contacts
Reach the right people with access to detailed contact information.
9
Corporate Relations
Get the big picture on a company's affiliates and who they do business with.
4
Close Industry Peers
See similar companies for insight and prospecting.
*Contacts and Principals counts are estimates and may differ from the actual number of contacts available in D&B Hoovers.